课题基金 / 基金详情

MOLECULAR MECHANISMS OF AMINOGLYCOSIDE RESISTANCE

MOLECULAR MECHANISMS OF AMINOGLYCOSIDE RESISTANCE
氨基糖苷抗性的分子机制
批准号:
2076764
负责人:
MARCELO E TOLMASKY
金额:
$9.68万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-06-01 至 2000-05-31

项目摘要

项目成果

MARCELO E TOLMASKY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Since the introduction of antibiotics, bacteria kept developing resistance to all of them. Drug companies kept pace by developing new antimicrobial agents so when a pathogen became resistant to one of them there was another that would be effective. However, recently many multiple-drug resistance pathogenic bacteria have emerged towards which most antibiotics are ineffective. As a consequence, the race between development of resistance by pathogens and the pharmaceutical industry is becoming worse. As the problem of bacterial resistance increases, the availability of effective antimicrobial agents to treat infections gets curtailed and the costs grow higher. An approach to deal with the drug resistance problem is to study different aspects of the mechanisms of bacterial resistance to antibiotics and design rational drug strategies to overcome the problem based on the knowledge gained. Aminoglycosides are important for the treatment of serious Gram-negative infections. A very common mechanism of bacterial resistance to aminoglycosides is to eliminate the antibacterial activity through enzymatic inactivation by the action of modifying enzymes. A clinically important N-acetyltransferase enzyme is AAC(6')-Ib which confers resistance to several aminoglycosides including the semisynthetic amikacin, the most refractory to inactivating enzymes. The long term goal of this investigation is to understand at the molecular level the different events that result in bacterial resistance to aminoglycosides mediated by this enzyme. The specific aims for this project are: 1) Determination of the subcellular localization of AAC(6')-Ib. The location of an aminoglycoside-modifying enzyme is instrumental in the determination of the level of resistance of a bacterial cell to a certain aminoglycoside. The subcellular location of the enzyme AAC(6')-Ib will be determined by: a) treatment of spheroplasts with proteases, b) imunoelectron microscopy, and c) gene fusions. These approaches will complement those analysis already done using physical methods that release periplasmic proteins. 2) Identification of amino acids and regions critical for the function of AAC(6')-Ib. Not all amino acid residues and regions of a protein contribute equally to the function and structure of an enzyme. Thus, the goal of this specific aim is to identify regions and amino acids residues of the protein AAC(6')-Ib that are critical for its structure and enzymatic function. This will be done using random replacement mutagenesis, a technique that allows [one] to assess the importance of small portions of the protein. 3) Crystallization of AAC(6')-Ib. An important step in the characterization of biological processes is the correlation of biochemical and genetic data with the detailed structure of the molecules involved. Therefore, a long-term objective of this project is to determine the three dimensional structure of AAC(6')-Ib. The goal for this proposal is to generate crystals suitable for high-resolution X-ray diffraction analysis. This will be achieved by: a) purification of sufficient amounts of AAC(6')-Ib and b) establishment of the condition to produce the crystals.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Bacterial resistance to aminoglycosides and beta-lactams: the Tn1331 transposon paradigm.
细菌对氨基糖苷类和 β-内酰胺类药物的耐药性:Tn1331 转座子范例。
DOI: 10.2741/tolmasky
发表时间: 2000
期刊: Frontiers in bioscience : a journal and virtual library
影响因子: --
作者: [Tolmasky,ME]
通讯作者: Tolmasky,ME
Characterization of mutants of the 6'-N-acetyltransferase encoded by the multiresistance transposon Tn1331: effect of Phen171-to-Leu171 and Tyr80-to-Cys80 substitutions.
多抗性转座子 Tn1331 编码的 6-N-乙酰转移酶突变体的表征:Phen171 至 Leu171 和 Tyr80 至 Cys80 取代的影响。
DOI: 10.1006/plas.1997.1330
发表时间: 1998
期刊: Plasmid
影响因子: 2.6
作者: [Panaite,DM, Tolmasky,ME]
通讯作者: Tolmasky,ME
CHERP Cancer Research Education Program
CHERP Administrative Core
1/2 CSUF/UCI-CFCCC Cancer Health Disparities Research Program (CHERP)
1/2 CSUF/UCI-CFCCC Cancer Health Disparities Research Program (CHERP)
海外基金